Working… Menu
Trial record 6 of 20 for:    Recruiting, Not yet recruiting, Active, not recruiting Studies | Alzheimer Disease | rochester, New York, U.S.

Study of BHV-4157 in Alzheimer's Disease (T2 Protect AD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03605667
Recruitment Status : Recruiting
First Posted : July 30, 2018
Last Update Posted : October 11, 2019
Alzheimer's Disease Cooperative Study (ADCS)
Information provided by (Responsible Party):
Biohaven Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 5, 2020
Estimated Study Completion Date : December 20, 2020